SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001256071-24-000003
Filing Date
2024-02-12
Accepted
2024-02-12 18:35:07
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G KaziaTherapeutics11.txt SC 13G 2071
  Complete submission text file 0001256071-24-000003.txt   3953
Mailing Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000
Business Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000 01161298780088
KAZIA THERAPEUTICS LTD (Subject) CIK: 0001075880 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: SC 13G | Act: 34 | File No.: 005-50612 | Film No.: 24621891
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O PLATINUM ASSET MANAGEMENT LEVEL 8, 7 MACQUARIE PLACE SYDNEY AUSTRALIA 2000 C3 00000
Business Address C/O PLATINUM ASSET MANAGEMENT LEVEL 8, 7 MACQUARIE PLACE SYDNEY AUSTRALIA 2000 C3 00000 61292557533
PLATINUM INVESTMENT MANAGEMENT LTD (Filed by) CIK: 0001256071 (see all company filings)

IRS No.: 000000000
Type: SC 13G